Dr. Lawrence E Flaherty MD
Hematologist-Oncologist | Hematology & Oncology
Karmanos Cancer Center 4100 John R Hwcrc 4t Detroit MI, 48201Rating
4/5
About
Dr. Lawrence Flaherty is a hematologist oncologist practicing in Detroit, MI. Dr. Flaherty specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Saint Louis University School of Medicine 1978
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Hematology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Rationale for intergroup trial E-3695 comparing concurrent biochemotherapy with cisplatin, vinblastine, and DTIC alone in patients with metastatic melanoma.
- Adjuvant high-dose interferon revisited.
- Weekly 1-hour infusion of paclitaxel. Clinical feasibility and efficacy in patients with hormone-refractory prostate carcinoma.
- Biochemotherapy for melanoma.
- Implications of microscopic satellites of the primary and extracapsular lymph node spread in patients with high-risk melanoma: pathologic corollary of Eastern Cooperative Oncology Group Trial E1690.
- Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: overall results of a randomized trial of the Southwest Oncology Group.
- Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: impact of HLA class I antigen expression on outcome.
- Risk assessment in localized primary cutaneous melanoma: a Southwest Oncology Group study evaluating nine factors and a test of the Clark logistic regression prediction model.
- Phase II trial of interferon and thalidomide in metastatic renal cell carcinoma.
- Phase II trial of pegylated interferon and thalidomide in malignant metastatic melanoma.
- Evaluation of interferon alpha-2B and thalidomide in patients with disseminated malignant melanoma, phase 2, SWOG 0026.
- Adjuvant therapy of melanoma: is pegylated interferon alfa-2b what we've been waiting for?
- Phase 2 trial of combination thalidomide plus temozolomide in patients with metastatic malignant melanoma: Southwest Oncology Group S0508.
- A phase II trial of imatinib mesylate in merkel cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group study (S0331).
- A phase 2 trial of complete resection for stage IV melanoma: results of Southwest Oncology Group Clinical Trial S9430.
Treatments
- Melanoma
- Skin Cancer
- Breast Cancer
- Lung Cancer
- Lymphoma
- Pain
Dr. Lawrence E Flaherty MD's Practice location
Practice At Karmanos Cancer Center 4100 John R Hwcrc 4th Fl
Karmanos Cancer Center 4100 John R Hwcrc 4t -Detroit, MI 48201Get Direction
Dr. Lawrence E Flaherty MD's reviews
Write ReviewPatient Experience with Dr. Flaherty
Recommended Articles
![]()
Morphos Declared a "Breakthrough Therapy" for LymphomaMorphoSys’s main objective is to design exceptional and unique biopharmaceuticals, all designed to enhance the lives of patients suffering from severe or life-threatening conditions.The human body has two types of lymphocytes that can develop into lymphomas: B lymphocytes (B cells) and T...
![]()
The Lymphoma Research Foundation's Light it Red for Lymphoma NightLymphoma, a cancer of the lymphatic system, currently affects over 700,000 Americans who are living with or in remission from the disease. Statistics show that every seven minutes, someone in the United States is diagnosed with the condition, which amounts to approximately 80,000 people per year.The...
- Treatment Options of Multiple Myeloma
A team led by a consultant haematology specialist takes care of you if you are a multiple myeloma patient. The team discusses your situation and suggests the best treatment for you, but you will finally decide.It may be paramount to compile a list of questions which you will ask the specialist...
![]()
Astonishing Clinical Trial Results Show Promise for Non-Hodgkin Lymphoma ResearchThere’s good news for those who’ve been diagnosed with the aggressive non-Hodgkin lymphoma (NHL) type referred to as diffuse large-B cell (DLBCL). According to the American Cancer Society (ACS), this type of HNL is the most common type of lymphoma.The descriptive letters clarify the type of...
![]()
Tips for Young Adult Lymphoma Survivors to Make the Most of RecoveryIt is extremely difficult to reenter the world and normal life after battling lymphoma. Recovery is much more than the body's physical battle, but how to balance emotions and relationships as well.However, there are specific tools that can assist in adapting back into a life that may seem...
![]()
Survey Shows Lack of Blood Cancer Knowledge Among AmericansIf anyone is asked to describe what cancer is, chances are they’ll be able to provide at least a rough definition of the disease. Generally speaking, cancer is the name for the rapid and uncontrollable development of cells in a certain part of the body. In addition to holding a general awareness...
Nearby Providers
![]()
Dr. Mitchell Ford Peabody D.O.12000 E 12 Mile Rd Warren MI 48093![]()
Dr. Tarik H. Hadid MD11900 E 12 MILE RD STE 308 WARREN MI 48093![]()
Dr. Zyad Kafri MD19229 Mack Ave Grosse Pointe Woods MI 48236![]()
Dr. Nalini Janakiraman M.D.Henry Ford Health System Detroit MI 48202![]()
Dr. Michael J Stender M.D.3577 W 13 Mile Rd Royal Oak MI 48073![]()
Dr. Voravit Ratanatharathorn MD FACP4100 John R St Detroit MI 48201
Nearest Hospitals
CHILDREN'S HOSPITAL OF MICHIGANl
3901 BEAUBIEN STREET DETROIT MI 48201DETROIT RECEIVING HOSPITAL & UNIV HEALTH CENTERl
4201 ST ANTOINE ST - 3M DETROIT MI 48201HENRY FORD HOSPITALl
2799 W GRAND BLVD DETROIT MI 48202